|
SEH1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.367740E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.209000E-04 |
| Normal-vs-Stage2 |
9.132000E-02 |
| Normal-vs-Stage3 |
2.118100E-03 |
| Normal-vs-Stage4 |
7.064100E-03 |
| Stage1-vs-Stage2 |
6.054200E-01 |
| Stage1-vs-Stage3 |
9.304000E-01 |
| Stage1-vs-Stage4 |
9.595200E-01 |
| Stage2-vs-Stage3 |
5.831800E-01 |
| Stage2-vs-Stage4 |
6.793600E-01 |
| Stage3-vs-Stage4 |
9.135400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.580790E-04 |
| Normal-vs-AfricanAmerican |
2.453500E-02 |
| Normal-vs-Asian |
3.238600E-03 |
| Caucasian-vs-AfricanAmerican |
4.044800E-01 |
| Caucasian-vs-Asian |
9.335400E-01 |
| AfricanAmerican-vs-Asian |
5.196600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.500500E-03 |
| Normal-vs-Female |
1.216790E-04 |
| Male-vs-Female |
5.203000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.163800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.336700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.370260E-02 |
| Normal-vs-Age(81-100Yrs) |
7.218400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.286200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.586800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.987200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.462000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.882000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.144000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.727200E-01 |
| Classical-VS-Follicular |
1.80399994942348E-09 |
| Classical-VS-Other |
1.175980E-01 |
| Classical-VS-Normal |
1.18989999964292E-07 |
| Tall-VS-Follicular |
7.480400E-03 |
| Tall-VS-Other |
3.051600E-01 |
| Tall-VS-Normal |
3.225800E-02 |
| Follicular-VS-Other |
6.680800E-01 |
| Follicular-VS-Normal |
4.188400E-01 |
| Other-VS-Normal |
8.765200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.756100E-02 |
| Normal-vs-N1 |
5.680200E-02 |
| N0-vs-N1 |
6.716600E-01 |
|
|
